Viewing Study NCT03546361


Ignite Creation Date: 2025-12-24 @ 1:06 PM
Ignite Modification Date: 2025-12-28 @ 9:51 PM
Study NCT ID: NCT03546361
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-14
First Post: 2018-05-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module